{
    "2018-10-15": [
        [
            {
                "time": "2018-10-12",
                "original_text": "医药生物行业2018年三季报业绩前瞻：医药需求刚性 预计增长保持稳健",
                "features": {
                    "keywords": [
                        "医药需求",
                        "刚性",
                        "三季报",
                        "业绩",
                        "增长"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "一线丨默沙东借力中国本地医药运营商推广广谱抗癌药",
                "features": {
                    "keywords": [
                        "默沙东",
                        "抗癌药",
                        "推广",
                        "运营商"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "[推荐评级] 医药行业周报：17种抗癌药纳入国家医保 研发驱动型企业长期受益",
                "features": {
                    "keywords": [
                        "抗癌药",
                        "医保",
                        "研发驱动",
                        "企业",
                        "长期受益"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "主力资金近三日都在买这些概念股",
                "features": {
                    "keywords": [
                        "主力资金",
                        "概念",
                        "买入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "医药行业专题：从最新估值看医药行业",
                "features": {
                    "keywords": [
                        "估值",
                        "医药行业",
                        "最新"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "生物医药行业: 第三批抗癌药医保谈判落地 以价换量期待结果",
                "features": {
                    "keywords": [
                        "抗癌药",
                        "医保",
                        "谈判",
                        "以价换量"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "医药行业周报: 估值吸引力强, 期待三季报行情",
                "features": {
                    "keywords": [
                        "估值",
                        "吸引力",
                        "三季报",
                        "行情"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}